Literature DB >> 12376483

Different genetic alterations in rat forestomach tumors induced by genotoxic and non-genotoxic carcinogens.

Masahiro Kaneko1, Keiichirou Morimura, Takayuki Nishikawa, Hideki Wanibuchi, Nobuyasu Takada, Harushi Osugi, Hiroaki Kinoshita, Shoji Fukushima.   

Abstract

Human beings are exposed to a multitude of carcinogens in their environment, and most cancers are considered to be chemically induced. Here we examined differences in genetic alterations in rat forestomach tumors induced by repeated exposure to a genotoxic carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) or N-methylnitrosourethane (MNUR), and chronic treatment with a non-genotoxic carcinogen, butylated hydroxyanisole (BHA) or caffeic acid (CA). A total of 132, 6-week-old male F344 rats were employed. Forty rats were treated with MNNG by intragastric administration at a dose of 20 mg/kg body wt once a week for 32 weeks, and 20 rats received 20 p.p.m. MNUR in their drinking water for 48 weeks. Further groups of 20 animals were administered 2% BHA or 2% CA in the diet for 104 weeks. The remaining rats were maintained without any supplement as controls. Multiple forestomach tumors were observed in all rats of the MNNG-, MNUR-, BHA- and CA-treated groups. Histopathologically, MNUR- and CA-treated groups showed almost the same pattern. On polymerase chain reaction-single strand conformation polymorphism analysis, H-ras and p53 gene mutations were observed at high and relatively low frequencies, respectively, in forestomach tumors induced by MNNG and MNUR. Most H-ras gene mutations were G-->A transitions in codons 7 and 12 of exon 1. On the other hand, forestomach tumors due to the non-genotoxic carcinogens, BHA and CA, had almost no mutations of the H-ras and p53 genes. Moreover, relative overexpression of cyclin D1 and p53 was detected in forestomach tumors induced by the genotoxic carcinogens, while their non-genotoxic counterparts had a tendency to show low expression of those molecules. Mutations of the beta-catenin gene were not detected in any group. The present study demonstrates that rat forestomach tumors induced by genotoxic and non-genotoxic carcinogens have different underlying genetic alterations, even if their pathological features are similar.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376483     DOI: 10.1093/carcin/23.10.1729

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  The Janeway gastrostomy tube for recurrent gastric intubations: a novel and simple animal model.

Authors:  Ali Ugur Emre; Guldeniz C Karadeniz; Oge Tascilar; Bulent H Ucan; Oktay Irkorucu; Kemal Karakaya; Mustafa Comert
Journal:  Dig Dis Sci       Date:  2007-10-12       Impact factor: 3.199

2.  Modulatory effects of Azadirachta indica on benzo(a)pyrene-induced forestomach tumorigenesis in mice.

Authors:  Subhash Chander Gangar; Rajat Sandhir; Durg Vijay Rai; Ashwani Koul
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 3.  Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays.

Authors:  Sundeep A Chandra; Michael W Nolan; David E Malarkey
Journal:  Toxicol Pathol       Date:  2009-12-17       Impact factor: 1.902

4.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

5.  MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.

Authors:  P Zhang; W M Tang; H Zhang; Y Q Li; Y Peng; J Wang; G N Liu; X T Huang; J J Zhao; G Li; A M Li; Y Bai; Y Chen; Y X Ren; G X Li; Y D Wang; S D Liu; J D Wang
Journal:  Br J Cancer       Date:  2017-06-20       Impact factor: 7.640

6.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.